Benzinga’s News Roundup (PLCE, ABT, RMIX, CVX)

Children's Place Retail Stores, Inc. (NASDAQ: PLCE) reported today a fourth-quarter net income of $34.1 million, or $1.23 per share, as compared to $38.8 million, or $1.31 per share, for the same quarter last year. Revenue increased to $462.8 million from $441.5 million in the year ago period. Analysts had expected PLCE to earn $1.04 per share on revenue of $462.8 million. Children's Place Retail Stores declined 2.49% to $39.90 in the pre-market session. The 52-week trading range for PLCE is $19.82 - $41.65. PLCE has surged over 52% in the last six months.

Abbott Laboratories (NYSE: ABT) announced today that it has received U.S. Food and Drug Administration approval for the TECNIS® Multifocal 1-Piece intraocular lens (IOL) for cataract patients with and without presbyopia. Abbott Laboratories increased 0.55% to $55.10 in the pre-market session. ABT closed at $54.80 in the last trading session. In the last year, ABT has gained over 16%.

U.S. Concrete, Inc. (NASDAQ: RMIX) reported today a fourth-quarter loss of $16.7 million, or $0.46 per share, as compared to $132.2 million, or $3.63 per share, for the same quarter last year. Revenue fell 31% to $119.9 million for the quarter. The 52-week trading range for RMIX is $0.55 - $2.75. RMIX closed at $0.581 in the previous trading session. In the last year, RMIX has declined over 59%.

Chevron Corporation (NYSE: CVX) was downgraded today by J.P. Morgan analyst Doug Leggate from Buy to Neutral and the price target set to $90. Chevron Corporation decreased 0.61% to $73.85 in the pre-market session. The 52-week trading range for CVX is $59.28 - $81.09. In the last trading session, CVX closed at $74.30. CVX has gained 27% in the last year.